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Background: Since the introduction of bone-anchored hearing aids (BAHAs) in the 1980s, the practices of surgeons
who implant these hearing aids have become varied; different indications and surgical techniques are utilized
depending on the surgeon and institution. The objective of the current study is to describe the clinical and surgical
practices of otolaryngologists in Canada who perform pediatric BAHA operations.
Methods: A detailed practice questionnaire was devised and sent to all members of the Canadian Society of
Otolaryngology-Head and Neck Surgery. Those who performed pediatric BAHA surgeries were asked to participate.
Results: Twelve responses were received (response rate of 80%). All of the respondents identified congenital aural
atresia to be an indication for pediatric BAHAs. Other indications were chronic otitis externa or media with hearing
loss (92%), allergic reactions to conventional hearing aids (75%), congenital fixation or anomaly of ossicular chain
(67%), and unilateral deafness (25%). Minor complications, such as skin reactions, were reported in 25% of cases,
while major complications were very rare. There was great variability with regards to surgical techinque and
post-operative management. The extent of financial support for the BAHA hardware and device also varied
between provinces, and even within the same province.
Conclusion: There is a lack of general consensus regarding pediatric BAHA surgeries in Canada. With such a small
community of otolaryngologists performing this procedure, we are hopeful that this survey can serve as an impetus
for a national collaboration to establish a set of general management principles and inspire multi-site research
ventures.
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The application of osseointegration for the purpose of
hearing rehabilitation was first introduced in 1977 [1].
Now, commonly referred to as bone-anchored hearing
aid (BAHA), this technique supplanted bone conduction
hearing aids, leading to a delivery of more robust
and higher quality sounds [2]. Such a system allows
for sound to be transmitted directly to the cochlea
through the cranium, circumventing any external or
middle ear anomaly or pathology. Numerous studies* Correspondence: ccliu@ucalgary.ca
1Division of Otolaryngology-Head and Neck Surgery, University of Calgary,
Calgary, AB, Canada
5Foothills Medical Centre, 1403-29 Street NW, South Tower Room 602,
Calgary, AB T2N 2T9, Canada
Full list of author information is available at the end of the article
© 2013 Liu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orhave confirmed the benefits of the BAHA system, or
a very similar system from Oticon Medical (Askim,
Sweden), the Ponto®, in terms of audiological outcome,
aesthetics, and health-related quality of life [2-6].
Since their commercial introduction in 1987, BAHAs
have become a common treatment option for patients
with conductive hearing loss who are either unsuitable for
or have failed conventional hearing aids [1-3,7]. Originally,
their use was limited to those with chronic otitis media [7],
yet with time the indications have grown to encompass
numerous conditions, including congenital ear anomalies,
chronic otitis externa or media, and single-sided deafness
[2-4,6-10]. Along with the escalation in indications, there
has been a divergence in the clinical and operative prac-
tices of otolaryngologists who perform pediatric BAHAThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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periences, different indications and techniques are uti-
lized, resulting in variable practices [7].
The present study describes the clinical and surgical
practices of otolaryngologists in Canada who perform
pediatric BAHA operations. Elucidating the trends and
variations in surgeon preferences and practices in one
country may inspire a national collaboration to establish
a set of general management principles with regards to
pediatric BAHAs. It may also serve as an impetus for
multi-site research ventures and information for policy








Nova Scotia 3 25
Newfoundland and Labrador 1 8
Academic institutionMethods
A practice survey questionnaire was devised by the au-
thors based on a review of the literature as well as from
acquired experiences. The survey consisted of 39 ques-
tions divided into general practice and surgical practice
sections (Additional file 1: Appendix A). The general
practice section comprised of questions regarding demo-
graphic information, including province of practice and
completion and type of training. Respondents were then
asked about their indications for pediatric BAHA surger-
ies as well as their use of the BAHA softband. Finally,
there were questions regarding the funding of unilateral
and bilateral BAHAs, replacement BAHAs, the BAHA
softband, and perioperative complications.
The surgical practice section of the questionnaire in-
quired about the placement of the BAHA implant in
microtia and non-microtia children, incision type, and
the use of dermatomes and bony augmentation. There
were also questions regarding the age of BAHA implant-
ation, indications for one- and two-staged procedures,
length of time in between stages, the placement/use of
sleeper implants, and patient follow-up.
The questionnaire was sent via email to all members
of the Canadian Society of Otolaryngology – Head and
Neck Surgery (CSO-HNS). Only those who performed
pediatric BAHAs were asked to respond. Two reminder
emails were sent over the course of three months.
Given that this study is not experimental in nature
and did not involve any patients or animals, exemption





Pediatric Otolaryngology 4 40
No 1 8
Not specified 1 8Results
A total of 12 responses were received. Specifically, a re-
sponse rate of 80% was obtained since there were 15
otolaryngologists performing pediatric BAHA operations
at the time of the survey in Canada [deduced from
contacting the BAHA manufacturers (Cochlear and
Oticon) and based on the pediatric BAHA surgeons
already known to the authors in different regions].General practice
Table 1 shows the demographic data of the respondents.
There were no representations from the provinces of
Saskatchewan, Manitoba and New Brunswick, and the
Yukon, Nunavut and Northwest Territories. This was
expected since these regions did not have a pediatric
BAHA program at the time of the survey. Eleven re-
spondents worked in academic institutions and 10 have
undergone fellowship training. Four were fellowship
trained in pediatric otolaryngology and six in otology/
neurotology. The average number of pediatric BAHAs
implanted each year per surgeon was 6.4 (range 1–20).
Table 2 summarizes the clinical practices of the re-
spondents. All respondents identified congenital aural
atresia to be an indication for performing pediatric
BAHAs. Other indications were chronic otitis externa or
media with hearing loss (92%), allergic reactions to con-
ventional hearing aids (75%), congenital fixation or
anomaly of the ossicular chain (67%), and unilateral
deafness (25%). Otologists who completed the survey
have a median of 4 indications (range 4 to 6), while
pediatric otolaryngologists have a median of 3 indica-
tions (range 2 to 5). None of the Canadian pediatric oto-
laryngologists stated unilateral deafness as an indication
for pediatric BAHAs.
In the management of external auditory canal atresia,
nine respondents (75%) primarily performed BAHAs.
For three of these respondents, the percentage of
children treated with BAHAs and canalplasties were 75-
80% and 20-25%, respectively. One surgeon reported
performing primarily canalplasties, and BAHAs were
Table 2 Summary of clinical practices
Respondents
Number Percent
Would you routinely offer a BAHA for congenital unilateral conductive hearing loss in children?
Yes 2 17
No 10 83
Indications for pediatric BAHAs
Congenital atresia of ear canal 12 100
Chronic otitis externa or media with hearing loss 11 92
Allergic reactions to standard hearing aids 9 75
Congenital fixation or anomaly of ossicular chain 8 67
Unilateral deafness 3 25
Trisomy 21 5 42
Treatment of external auditory canal atresia
Primarily canalplasty 1 8
Primarily BAHA 9 75
50% canalplasty, 50% BAHA 1 8
Complete canal atresia - BAHA, partial canal stenosis - canalplasty 1 8
Have you ever performed bilateral BAHAs in children? How many?
Yes - 1-3 4 33
Yes - 5 1 8
Yes - 10-15 1 8
No 6 50
Do you routinely use the BAHA softband in children if indicated?
Yes 11 92
No 1 8





No response 1 8
Do you have a dedicated BAHA audiologist at your institution?
Yes 11 92
No 1 8
Have you ever implanted other devices? (e.g., Vibrant Soundbridge) for pediatric conductive hearing loss?
Yes 1 8
No 11 92
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successful canalplasty outcomes. All respondents with
subspecialty training in pediatric otolaryngology used
BAHAs as the primary treatment for external auditory
canal atresia. For those with training in otology/
neurotology, BAHAs were used as primary treatment
for three (50%) respondents.Costs associated with bilateral BAHAs were reportedly
covered in the practice areas of seven respondents (58%,
Table 3). Of these, four respondents reported full cost
coverage for all BAHA-related components. One respond-
ent did not specify and two reported partial coverage. Three
respondents (25%) reported full coverage for the first
BAHA only and two (17%) reported only partial coverage
Table 3 Funding for costs associated with bilateral BAHAs
Province Funding, partial
(P)/full (F)











AB Yes (F) – – Yes Yes
AB Yes (P) Procedure Charity
foundation
Yes Yes
ON Yes (F) – – Yes No
ON Yes (F) – – No No
ON No Full coverage for one BAHA Private
insurance
No Yes
QC No Partial funding for one BAHA - implant,
processor
None No No
QC Yes (P) Procedure Charity
foundation
No No
NS No Full coverage for one BAHA Private
insurance
No Yes
NS Yes (−) – – Yes Yes
NS Yes (F) – – Yes Yes
NL No Full coverage for one BAHA None No Yes
– No response.
* Coverage of BAHA softband in the absence of an implanted BAHA.
BC - British Columbia, AB - Alberta, ON - Ontario, QC - Quebec, NS - Nova Scotia, NL - Newfoundland and Labrador.
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reported the availability of government funding for replace-
ment BAHAs.
Six surgeons (50%) have performed bilateral BAHAs in
children, ranging from one to 15 cases each. The main
indications included bilateral external auditory canal
atresia and inability to wear conventional hearing aids,
bilaterally. Costs associated with bilateral BAHAs were
covered (either fully or partially) in the practice regions
of five of the six surgeons (83%) who have performed
this procedure in children. There was no coverage for
bilateral BAHAs in the practice regions of four of the six
surgeons (67%) who have not performed this procedure
in children. Eleven out of 12 respondents (92%) reported
that they routinely use the BAHA softband in young
children when indicated. The BAHA softband was
funded in most regions.
Minor complications, which mainly included skin re-
actions, cellulitis and soft-tissue infections, were reported
to affect 25% of pediatric patients. Major complications
(loss of implant, hematoma and complete skin over-
growth) were reported in less than 5%.
Surgical practice
Table 4 summarizes the surgical practices of those who
responded to the survey. Eight respondents gave specific
measurements for placement of the BAHA implant. The
most commonly reported distance was 5 to 5.5 cm
posterosuperior from the ear canal opening (or assumedopening in atretic ears), and 42% reported altering the
implant site in children with microtia compared to chil-
dren with normal auricles.
Incision type varied (42% linear; 58% U-shaped) and
25% routinely performed pre-operative imaging to assess
the thickness and quality of the cranial bone. One quar-
ter of the respondents reported using Gortex® or other
forms of bone augmentation in select cases.
Nine respondents (75%) stated that bone thickness
was the main determinant of the length of fixture used
(3 mm versus 4 mm). Of these nine responses, five
stated that they would always attempt to use a 4 mm
fixture unless the bone thickness is incompatible, in
which case a 3 mm fixture will then be implanted. For
one surgeon, 4 mm fixtures were always used regardless
of bone thickness. Finally, one listed age, rather than
bone thickness, as the main determinant of fixture
selection.
The wait time between the first and second stage of
the procedure ranged from 3 to 12 months. Of those
who provided specific timelines, the majority (86%)
waited from 3 to 6 months. Time elapsed between sec-
ond stage and the placement of the sound processor
ranged from 7 to 90 days. Seven out of 11 (64%) sur-
geons routinely placed a sleeper (back-up) implant and
three have had to use these back-up implants in the
past.
The mean age for performing BAHA surgery was 4
years (range 1.5 to 6 years).
Table 4 Summary of surgical practices
Respondents
Number Percent
For patients with microtia, do you consult the reconstructive ear surgeon for advice on implant location?
Yes 9 75
No 3 25
Location of implant for non-microtia children
3.5-4.5 cm posterosuperior to EAC 2 17
5.0-5.5 cm posterosuperior to EAC 5 42
6.5 cm posterosuperior to EAC 1 8
Posterosuperior to EAC, measurement not specified 2 17
No answer 2 17
Location of implant for microtia children
Same as for non-microtia children 4 33
Further posteriorly or superiorly 5 42
Variable 1 3
No answer 2 17
What are your indications for 2-staged procedures in children?
Bone thickness/condition and age 6 50
Bone thickness/condition only 2 17
Age only 2 17
Single stage procedures only 1 8







Do you perform pre-operative imaging to assess the thickness or quality of the bone?
Yes 3 25
No 8 67
No answer 1 3
Do you use Gortex® or other bony augmentation?
Yes 3 25
No 9 75





What are your indications for a 3 mm versus 4 mm fixture?
Bone thickness 9 75
4 mm preferred, 3 mm fixtures used if there is inadequate bone thickness 5/9 56
4 mm fixtures used in 80% of cases, 3 mm in 20% of cases 2/9 22
3 mm fixtures typically used in young children 2/9 22
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Table 4 Summary of surgical practices (Continued)
4 mm fixtures regardless of bone thickness 1 8
Age 1 8
No answer 1 8
Length of time between 1st and 2nd stage? (months)
3 1 8
4-6 4 33
3 for children >6yo, 6 for children <6yo 1 8
6-12 depending on age and bone quality 1 8
No timeline specified but depends on age and bone thickness/quality 1 8
Only perform single-stage surgeries 1 8
No answer 3 25
Do you use of a mastoid dressing after the 1st stage procedure?
Yes 9 75
No 2 17
No answer 1 8
Do you routinely admit children after stage 1 or 2 procedures?
Yes 6 50
No 5 42
No answer 1 8
Do you routinely place a sleeper implant during a pediatric case?
Yes 7 58
No 4 33
No answer 1 8




4% of cases 1/7 14
Do you perform soft-tissue reduction during the 1st or 2nd stage?
1st stage 2 17
2nd stage 8 67
No answer 2 17





How often do you see pediatric BAHA patients have a successful operation?
Every 1 month, then every 12 months 1 8
Every 3 months, then every 6 months 1 8
Every 6–12 months 9 75
Every 6 months for 24 months, then every 12 months 1 8
EAC - external auditory canal.
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Our findings show that there is variability in the clinical
and surgical practices of otolaryngologists who perform
pediatric BAHA surgeries in Canada. This is consistent
with the divergence in practice that is reported in litera-
ture [7]. There is inconsistency among respondents with
regards to using unilateral hearing loss and trisomy 21
as indications for BAHA implantation. The practice of
bilateral BAHA implantation as well as the minimum ac-
ceptable age for implantation also varies. Finally, there is
significant regional variation in funding for the BAHA
surgery, implant, and processor.
Overall, the least commonly reported indication for
BAHA implantation was unilateral hearing loss. The
utility of BAHAs in these patients is mainly to establish
binaural hearing [11,12]. The reported audiological ben-
efits, however, have been variable in this particular situ-
ation, especially in the pediatric population [11,13-15].
In their study of children and adolescents with unilateral
hearing loss, Priwin et al [14]. did not find any improve-
ments in hearing thresholds or sound localization with
the BAHA. They did, however, note an improvement in
speech recognition, especially in noisy environments.
This correlates with other studies in which participants
have reported using the BAHA mainly in classrooms
[11]. Despite the inconsistencies in reported audiological
benefits, BAHAs in children with unilateral hearing loss
have been found to have a positive impact on quality of
life with high rates of user compliance [14-16]. This may
suggest that children experience a subjective benefit
even if audiological measurements do not always corres-
pond. Twenty-five percent of our respondents listed
unilateral hearing loss as an indication for BAHA im-
plantation, and only 17% routinely offered this treatment
to children with congenital unilateral hearing loss. This
indicates that the majority has not accepted BAHAs as a
beneficial intervention for this cohort of children, which
seems appropriate at the current level of evidence.
Trisomy 21 was another uncommon indication ac-
cording to our respondents (Table 2). Children with tri-
somy 21 have eustachian tube dysfunction, leading to
chronic otitis media with effusion and often, conductive
hearing loss [17]. Bone anchored hearing aids have been
shown to be beneficial in these children when other
methods of re-establishing hearing (ventilation tubes
and conventional hearing aids) are unsuccessful [17,18].
Despite these results, there appears to be a trend of
underutilization of BAHAs in some syndromic children
[6]. The lower proportion of respondents who use tri-
somy 21 as an indication for BAHA implantation may
be interpreted to be a reflection of this trend. This may
be due to a lack of awareness regarding the benefits of
BAHAs in children with trisomy 21 [6]. Increased
awareness and education can therefore be helpful inencouraging otolaryngologists to consider BAHAs as a
viable option for hearing restoration in this population
in some situations.
The benefits of bilateral BAHA implantation have
been debated in the literature [19]. Due to the small at-
tenuation of vibrations in the skull, it has been argued
that one BAHA can also stimulate the cochlea on the
opposite side [10,20]. There have been studies, however,
which report improved audiological outcomes and qual-
ity of life in children fitted with bilateral BAHAs
[16,21,22], indicating that there may be a role for this
intervention in some children. Fifty percent of our re-
spondents have performed bilateral BAHAs in children.
Interestingly, most surgeons (83%) who have performed
bilateral BAHAs practice in an area where the procedure
is partially or fully funded, whereas most of those who
have not performed this procedure (67%) work in areas
where bilateral BAHAs are not funded. It is possible that
in the small population of children who may benefit
from this intervention, bilateral BAHAs are underused
as a result of funding limitations. A similar trend is
expected in many other countries since health care
funding is becoming more scarce. As we will discuss
later on, there is a need for more comprehensive cover-
age for the BAHA procedure and related costs. We en-
courage otolaryngologists who practice in regions with
funding limitations to advocate for more adequate cover-
age, especially in situations where the lack of funding
may be the obstacle to an intervention that is known to
lead to improved outcomes, such as bilateral BAHA im-
plantation in select cases [19].
There is no consensus on the ideal age for BAHA im-
plantation in children [6,9]. Achieving optimal hearing
earlier in life best facilitates normal speech and language
development [23,24]. Younger age at the time of inter-
vention, however, is associated with an increased risk of
osseointegration failure [3,9]. This is most likely due to
thinner temporal bones [9] as well as the higher water
and lower mineral content associated with younger
skulls [25]. Other factors that may contribute to failure
in younger children include an increased risk of trauma
and a decreased ability to care for the implant site
[3,25]. The trend reported in literature is to implant
BAHAs in children older than 4 years of age [7]. Others
state that children older than 3 years should have ad-
equate bone thickness, and therefore would make suit-
able BAHA candidates [1]. Our results show that 4 years
is the most commonly accepted minimum age for
BAHA implantation (42%), followed by 3 years (25%)
and 5–6 years (25%). The BAHA softband is routinely
fitted for children younger than this for 92% of respon-
dents. Our results imply that there are some children in
Canada who are being delayed the BAHA operation sec-
ondary to surgeon practices/preferences. By elucidating
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performing this procedure in children at age 3–4 years,
perhaps those waiting until age 5–6 years would con-
sider implanting the BAHA at an earlier age. This is im-
portant since the BAHA processor with implanted
abutment has been shown to yield better audiologic re-
sults compared to the BAHA headband alone [26].
Therefore, children would benefit from earlier implant-
ation as soon as they are physiologically/anatomically
ready to receive the implant.
Similar to how age and bone thickness dictate the tim-
ing of the BAHA surgery, these factors were also
reported to determine the details of the procedure. Half
of the respondents stated that young age and thin tem-
poral bone are indications for two-staged procedure.
Few (17%) only considered bone thickness and another
17% only considered age. This is consistent with the lit-
erature, where surgeons have reported age and bone
thickness to be the major determinants in deciding be-
tween a one- or two-staged operation [3,13,25]. Some
have reported performing two-staged procedure in chil-
dren with less than 2.5 mm of bone thickness [25]. Simi-
larly, there is support for one-staged procedure in older
children whose bone thickness would allow for the im-
plantation of a 4 mm fixture [3].
One of the most striking results seen in our survey is
the variability in the availability and extent of funding
for the BAHA surgery, implant, and processor. In some
cases, this inconsistency in funding was found to exist
even within the same province. Furthermore, there was
a lack of reliable funding for post-operative care (e.g., for
replacement BAHA sound processors). Others in the
past have also recognized the need for more comprehen-
sive funding programs in Canada [8]. Interestingly, one
of the challenges encountered is that the BAHA is often
considered to be a surgical procedure and not a hearing
aid. This distinction can be important since some private
health insurance companies provide coverage for hearing
aids but not for surgical procedures (or costs related to
surgeries). Subsequently, a major challenge identified by
parents, which may contribute to a delayed provision of
hearing aids, is having to self-fund the costs [27,28]. We
hope that by highlighting this discrepancy and possible
inadequacy in funding, we are able to encourage a con-
certed effort among this small group of practitioners to
advocate for more extensive coverage for BAHAs for the
indicated cases. Obviously, the situations can be quite
different in countries such as the United States, where
the healthcare funding does not come from a single
payer. Yet, many developed nations will have similar
funding issues as the ones identified in our survey.
Also, even places like the United States may soon have
to deal with “rationing” health care resources due to
rising costs.The limitation of the present study is evident in the sur-
vey format, which implies reporting and recall bias. A de-
tailed chart review of all pediatric BAHA patients may
have avoided these biases but it was not practical. Also,
the low sample size can be considered a limitation. How-
ever, this small sample size reflects the small group of sur-
geons in Canada who perform this procedure in children.
This is in keeping with the overall small number of chil-
dren that require this operation and the vast geographical
spread with concentrated populations at urban settings. As
well, several Provinces and Territories do not have enough
population to support their own pediatric BAHA program,
which is evident in our survey results. Other countries or
regions may have similar findings with a small number of
surgeons performing pediatric BAHA operations.
Conclusion
There is some agreement among otolaryngologists in
Canada who perform pediatric BAHA surgeries. Specif-
ically, the predominant indications for BAHA implant-
ation are clear. The remainder of our findings showed a
varied set of general and surgical practices among those
who perform this procedure in children. It also high-
lights the discrepancy in government funding across
provinces for unilateral and bilateral BAHAs, as well as
the BAHA softband.
Given this variation, a national forum would be benefi-
cial to allow for the discussion of the inconsistent prac-
tices and contentious issues in BAHA implantation.
Specifically, such a forum should establish the types of
patients/situations in which unilateral hearing loss would
be an indication for BAHA implantation, or when bilat-
eral BAHA implantation should be considered. Further-
more, awareness needs to be raised for surgeons caring
for children with Trisomy 21 as to when BAHA implant-
ation may become a viable option. Establishing a set of
general practice guidelines in pediatric BAHA surgeries
will help ensure that care of these children is as
evidence-based as possible. We also hope that this study
has raised questions that will inspire multi-institutional
research collaborations.
Finally, we encourage otolaryngologists performing
BAHA surgeries to become familiar with the various
sources of funding available in their regions and to
advocate for more comprehensive coverage if a need is
identified, both individually at the local level and
collectively at the provincial and national levels.
Additional file
Additional file 1: Appendix A – The Canadian Pediatric Bone-
Anchored Hearing Aid Clinical and Surgical Practice Questionnaire.
This is the survey used in this study, consisting of 39 questions divided
into general practice and surgical practice sections.
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